Showing results for "#Lancet study"
COVID-19 second-leading cause of death globally in 2021, slashed life...
Death rates too followed a similar trend, rising by 8.1 per cent in 2020 and an additional 5.2 per cent in 2021, the study estimated.
People with joint, muscle disorders expected to increase by 115 pc by...
The musculoskeletal disorders studied were a large and growing source of disability in the world that requires public policy consideration
One billion people globally to have osteoarthritis by 2050: Lancet...
Currently, 15 per cent of the world's population aged 30 years or above experience osteoarthritis, the study found after analysing 30 years of...
'Over 800 million people globally may suffer back pain by 2050'
The landscape of back pain cases is set to shift, with the biggest increases in back pain cases to be in Asia and Africa, said researchers from the...
COVID-19: Covaxin 50 percent effective when delta was dominant, shows...
Study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease...
Covaxin 77.8 pc effective against COVID-19: Lancet study
Bharat Biotech's vaccine Covaxin has demonstrated that it is 77.8 per cent effective against symptomatic Covid-19, through evaluation of 130 confirmed...
Novel coronavirus cannot pass from mother to child late in pregnancy:...
The 2019 novel coronavirus disease (COVID-19) may not pass to the child in the womb during late pregnancy, or cause severe health outcomes in a...
